VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia.
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia. Br J Haematol. 2003 Nov; 123(3):436-41.
View in:
PubMed
subject areas
Acute Disease
Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors
Biomarkers
Fibroblast Growth Factor 2
Hepatocyte Growth Factor
Humans
Leukemia, Myeloid
Middle Aged
Recurrence
Ribonuclease, Pancreatic
Thalidomide
Treatment Outcome
Tumor Necrosis Factor-alpha
Vascular Endothelial Growth Factor A
authors with profiles
HAGOP M KANTARJIAN
JORGE E CORTES